OMID (Omid Holdings) Net Margin %: 0.00% (As of . 20)


What is Omid Holdings Net Margin %?

Omid Holdings OMID -0.01% Net Margin % is 0.00% as of . 20.

Net margin is calculated as Net Income divided by its Revenue. Omid Holdings's Net Income for the three months ended in . 20 was $0.00 Mil. Omid Holdings's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, Omid Holdings's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Omid Holdings's Net Margin % or its related term are showing as below:


OMID's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.56
* Ranked among companies with meaningful Net Margin % only.

Omid Holdings  (OTCPK:OMID) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Omid Holdings Net Margin % Related Terms


Omid Holdings Net Margin % Historical Data

* Premium members only.

The historical data trend for Omid Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omid Holdings Net Margin % Chart

Omid Holdings Annual Data
Trend
Net Margin %

Omid Holdings Quarterly Data
Net Margin %

Omid Holdings Net Margin % Competitor Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omid Holdings Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Omid Holdings's Net Margin % falls into.



Omid Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Omid Holdings's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Omid Holdings's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Omid Holdings (OMID) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on Omid Holdings and its competitors.
Is Omid Holdings' Net Margin % too high?
Omid Holdings' current Net Margin % is 0.00%.
How does Omid Holdings' Net Margin % compare to competitors?
Omid Holdings' Net Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Omid Holdings and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omid Holdings's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omid Holdings stock overvalued right now?
Omid Holdings (OMID) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Omid Holdings (OMID), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omid Holdings Business Description

Address 1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a publicly-traded health and wellness company that operates a GMP-certified manufacturing facility in Alpha, NJ. The company utilizes its strengths in research, design, development, manufacturing, and marketing to produce a types of products for its internal brands. The company also offers its services as a contract manufacturer for private label brands. With a diverse portfolio of product types, OMID specializes in formulations that contain cannabis extracts as well as other herbal ingredients. The company's objective is to provide quality, integrity, and value to its clients in all of its finished consumer goods.